Paul E. Carrington

1.5k total citations
16 papers, 616 citations indexed

About

Paul E. Carrington is a scholar working on Molecular Biology, Endocrinology, Diabetes and Metabolism and Surgery. According to data from OpenAlex, Paul E. Carrington has authored 16 papers receiving a total of 616 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Molecular Biology, 8 papers in Endocrinology, Diabetes and Metabolism and 5 papers in Surgery. Recurrent topics in Paul E. Carrington's work include Diabetes Treatment and Management (8 papers), Neuropeptides and Animal Physiology (4 papers) and Pancreatic function and diabetes (4 papers). Paul E. Carrington is often cited by papers focused on Diabetes Treatment and Management (8 papers), Neuropeptides and Animal Physiology (4 papers) and Pancreatic function and diabetes (4 papers). Paul E. Carrington collaborates with scholars based in United States, Italy and Germany. Paul E. Carrington's co-authors include Alessandro Pocai, Donald J. Marsh, Ranabir SinhaRoy, Michael J. Maroney, Cristinel Sandu, Yufeng Wei, Milton H. Werner, Justine M. Hill, Evripidis Gavathiotis and Elisabetta Bianchi and has published in prestigious journals such as Journal of the American Chemical Society, Molecular Cell and PLoS ONE.

In The Last Decade

Paul E. Carrington

16 papers receiving 608 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Paul E. Carrington United States 11 328 230 117 81 80 16 616
Nils L. Johansen Denmark 13 702 2.1× 633 2.8× 352 3.0× 85 1.0× 101 1.3× 22 1.2k
Jeremy Wright United States 17 290 0.9× 80 0.3× 66 0.6× 41 0.5× 29 0.4× 41 741
Rita Sigmund United States 18 759 2.3× 136 0.6× 38 0.3× 38 0.5× 40 0.5× 22 936
Yen-Hao Chen United States 15 225 0.7× 122 0.5× 58 0.5× 18 0.2× 28 0.3× 20 777
Mika Fujimoto Japan 11 220 0.7× 33 0.1× 33 0.3× 16 0.2× 68 0.8× 41 745
Michal Koc Czechia 17 327 1.0× 29 0.1× 60 0.5× 32 0.4× 21 0.3× 37 746
Maura Fanti Italy 10 163 0.5× 47 0.2× 44 0.4× 39 0.5× 41 0.5× 20 514
L. Bokser United States 15 262 0.8× 217 0.9× 23 0.2× 15 0.2× 20 0.3× 25 752
Kenneth Huang United States 13 454 1.4× 68 0.3× 34 0.3× 24 0.3× 6 0.1× 20 623
Ronald W. Steigerwalt United States 13 260 0.8× 55 0.2× 108 0.9× 19 0.2× 12 0.1× 22 452

Countries citing papers authored by Paul E. Carrington

Since Specialization
Citations

This map shows the geographic impact of Paul E. Carrington's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Paul E. Carrington with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Paul E. Carrington more than expected).

Fields of papers citing papers by Paul E. Carrington

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Paul E. Carrington. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Paul E. Carrington. The network helps show where Paul E. Carrington may publish in the future.

Co-authorship network of co-authors of Paul E. Carrington

This figure shows the co-authorship network connecting the top 25 collaborators of Paul E. Carrington. A scholar is included among the top collaborators of Paul E. Carrington based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Paul E. Carrington. Paul E. Carrington is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

16 of 16 papers shown
1.
Huang, Chunhui, Anandan Palani, Qiaolin Deng, et al.. (2022). Discovery of Insulin/GLP-1/Glucagon Triagonists for the Treatment of Diabetes and Obesity. ACS Medicinal Chemistry Letters. 13(8). 1255–1261. 1 indexed citations
2.
Palani, Anandan, Andrea R. Nawrocki, Federica Orvieto, et al.. (2022). Discovery of MK-1462: GLP-1 and Glucagon Receptor Dual Agonist for the Treatment of Obesity and Diabetes. ACS Medicinal Chemistry Letters. 13(8). 1248–1254. 6 indexed citations
3.
Lin, Ken Y., et al.. (2020). LXR agonists promote lipid droplet formation in RPE cells. Investigative Ophthalmology & Visual Science. 61(7). 3114–3114. 1 indexed citations
4.
Lamy, Ricardo, Suzette Farber-Katz, Gulesi Ayanoglu, et al.. (2020). Comparative Analysis of Multiplex Platforms for Detecting Vitreous Biomarkers in Diabetic Retinopathy. Translational Vision Science & Technology. 9(10). 3–3. 11 indexed citations
5.
McLaren, David G., et al.. (2020). Impact of Extracellular Fatty Acids and Oxygen Tension on Lipid Synthesis and Assembly in Pancreatic Cancer Cells. ACS Chemical Biology. 15(7). 1892–1900. 11 indexed citations
6.
Demartis, Anna, Armin Lahm, Licia Tomei, et al.. (2018). Polypharmacy through Phage Display: Selection of Glucagon and GLP-1 Receptor Co-agonists from a Phage-Displayed Peptide Library. Scientific Reports. 8(1). 585–585. 9 indexed citations
7.
More, Vijay R., Julie Lao, David G. McLaren, et al.. (2017). Glucagon like receptor 1/ glucagon dual agonist acutely enhanced hepatic lipid clearance and suppressed de novo lipogenesis in mice. PLoS ONE. 12(10). e0186586–e0186586. 21 indexed citations
8.
Miller, Corin O., Jin Cao, Brande Thomas-Fowlkes, et al.. (2017). GPR40 partial agonist MK-2305 lower fasting glucose in the Goto Kakizaki rat via suppression of endogenous glucose production. PLoS ONE. 12(5). e0176182–e0176182. 10 indexed citations
9.
Bianchi, Elisabetta, Paul E. Carrington, Paolo Ingallinella, et al.. (2013). A PEGylated analog of the gut hormone oxyntomodulin with long-lasting antihyperglycemic, insulinotropic and anorexigenic activity. Bioorganic & Medicinal Chemistry. 21(22). 7064–7073. 40 indexed citations
10.
Kosinski, Jennifer, James Hubert, Paul E. Carrington, et al.. (2012). The Glucagon Receptor Is Involved in Mediating the Body Weight‐Lowering Effects of Oxyntomodulin. Obesity. 20(8). 1566–1571. 90 indexed citations
11.
Day, Jonathan W., Vasily M. Gelfanov, David L. Smiley, et al.. (2012). Optimization of co‐agonism at GLP‐1 and glucagon receptors to safely maximize weight reduction in DIO‐rodents. Biopolymers. 98(5). 443–450. 111 indexed citations
12.
Santoprete, Alessia, Elena Capitò, Paul E. Carrington, et al.. (2011). DPP‐IV‐resistant, long‐acting oxyntomodulin derivatives. Journal of Peptide Science. 17(4). 270–280. 53 indexed citations
13.
Carrington, Paul E., Cristinel Sandu, Yufeng Wei, et al.. (2006). The Structure of FADD and Its Mode of Interaction with Procaspase-8. Molecular Cell. 22(5). 599–610. 149 indexed citations
14.
Carrington, Paul E., et al.. (2003). Nickel coordination is regulated by the DNA-bound state of NikR. Nature Structural Biology. 10(2). 126–130. 58 indexed citations
15.
Carrington, Paul E., et al.. (2002). Use of XAS for the elucidation of metal structure and function: applications to nickel biochemistry, molecular toxicology, and carcinogenesis.. Environmental Health Perspectives. 110(suppl 5). 705–708. 16 indexed citations
16.
Tang, Qun, Paul E. Carrington, Yih‐Chern Horng, et al.. (2002). X-ray Absorption and Resonance Raman Studies of Methyl-Coenzyme M Reductase Indicating That Ligand Exchange and Macrocycle Reduction Accompany Reductive Activation. Journal of the American Chemical Society. 124(44). 13242–13256. 29 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026